Essentials of Stem Cell Biology / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $2.53
Usually ships in 1-2 business days
(Save 98%)
Other sellers (Hardcover)
  • All (11) from $2.53   
  • New (4) from $157.96   
  • Used (7) from $2.53   
Close
Sort by
Page 1 of 1
Showing All
Note: Marketplace items are not eligible for any BN.com coupons and promotions
$157.96
Seller since 2014

Feedback rating:

(1)

Condition:

New — never opened or used in original packaging.

Like New — packaging may have been opened. A "Like New" item is suitable to give as a gift.

Very Good — may have minor signs of wear on packaging but item works perfectly and has no damage.

Good — item is in good condition but packaging may have signs of shelf wear/aging or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Acceptable — item is in working order but may show signs of wear such as scratches or torn packaging. All specific defects should be noted in the Comments section associated with each item.

Used — An item that has been opened and may show signs of wear. All specific defects should be noted in the Comments section associated with each item.

Refurbished — A used item that has been renewed or updated and verified to be in proper working condition. Not necessarily completed by the original manufacturer.

New
Brand New Book, USA Edition, Hardcover, Shrink Wrapped, Fast Shipping, Essentials of Stem Cell Biology by Robert Lanza, Brigid Hogan, Douglas Melton, Roger Pedersen, James ... Thomson, E. Thomas, Michael West Read more Show Less

Ships from: Chicago, IL

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
$175.00
Seller since 2014

Feedback rating:

(151)

Condition: New
Brand new.

Ships from: acton, MA

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
$175.00
Seller since 2014

Feedback rating:

(151)

Condition: New
Brand new.

Ships from: acton, MA

Usually ships in 1-2 business days

  • Standard, 48 States
  • Standard (AK, HI)
$196.36
Seller since 2014

Feedback rating:

(267)

Condition: New
Brand New Item.

Ships from: Chatham, NJ

Usually ships in 1-2 business days

  • Canadian
  • International
  • Standard, 48 States
  • Standard (AK, HI)
  • Express, 48 States
  • Express (AK, HI)
Page 1 of 1
Showing All
Close
Sort by

Overview

First developed as an accessible abridgement of the successful Handbook of Stem Cells, this book serves the needs of the evolving population of scientists, researchers, practitioners and students that are embracing the latest advances in adult and embryonic stem cell research. Since the last edition was published, stem cell research has evolved into an important research tool, and stem cells have come to represent potential salvation for many people suffering from incurable diseases. Dr. Lanza is a prominent figure not only in the world of life sciences but is recognized publicly through the broad media coverage of his research.

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Ellen Mary Andrews, Ph.D.(Midwestern University)
Description: As a comprehensive primer of stem cell biology, this book covers the basics of stem cell biology, various types of stem cells in health and disease, the therapeutic potential of stem cells, and stem cell methodology. This is an update of the second edition, which was published in 2009.
Purpose: The goal is to review the field, with a focus on basic stem cell biology, concepts, methods, and therapeutic potential. This update is necessary to keep up with changes in the field and to properly educate students in stem cell biology.
Audience: The intended audience includes both students and general readers interested in stem cell advances, and the book would be ideal for a graduate student course or upper level undergraduate course. The book assumes a knowledge of basic embryology. The extensive glossary will be helpful to stem cell beginners.
Features: The six sections include an introduction to stem cells, basic biology and mechanisms, tissue and organ development, methods, applications, and regulations and ethics. The book begins with a short history of stem cell research, as well as basic definitions and stem cell types. The next section covers the concepts of stem cell niches, phenotypic changes of stem cells, and self-renewal. The section on tissue and organ development reviews the basic embryology of various tissue types and organs, focusing on the stem cell of each tissue/organ type. Each chapter also discusses embryonic stem cell induction of that tissue type/organ (for example, various neuronal cell types that have been induced from embryonic stem cells and the basic conditions necessary to do so). Each chapter ends with the therapeutic application or potential of stem cell induction for diseases and disorders that are common to that particular tissue or organ. The methods section covers induction of pluripotent cells, derivation and properties of embryonic stem cells, and murine embryonic stem cells and human embryonic stem cells. The applications section discusses the therapeutic applications and potential of stem cells in treating various diseases and disorders, ranging from neurodegenerative diseases to burns, heart disease, and muscular dystrophy. The final section briefly discusses the ethics of stem cell research. Interestingly, there is also a chapter that covers the FDA regulatory process, which is of great importance for students and scientists in industry.
Assessment: This book offers a thorough review of current research and therapeutic potential in the field of stem cell biology. The focus is on the therapeutic potential of stem cells, with the discussion of the current state of stem cell knowledge and stem cell therapies in various organs and tissues. Although the target audience seems to be graduate students, any scientists interested in studying the field would benefit from this book's thorough treatment of the subject.
From the Publisher
"…serves the needs of the evolving population of scientists, researchers, practitioners, and students embracing the latest advances in stem cells…From basic biology, early development, ectoderm, mesoderm, endoderm, and methods to the application of stem cells to specific human diseases, regulation and ethics, and patient perspectives, no topic in the field of stem cells is left uncovered."—Anticancer Research 34, 2014 "This book offers a thorough review of current research and therapeutic potential in the field of stem cell biology. The focus is on the therapeutic potential of stem cells, with the discussion of the current state of stem cell knowledge and stem cell therapies in various organs and tissues…any scientists interested in studying the field would benefit from this book's thorough treatment of the subject."Rating: 4 Stars—Doody.com, March 7, 2014
Read More Show Less

Product Details

  • ISBN-13: 9780120884421
  • Publisher: Elsevier Science
  • Publication date: 11/22/2005
  • Edition description: Older Edition
  • Edition number: 1
  • Pages: 584
  • Product dimensions: 8.74 (w) x 11.18 (h) x 1.28 (d)

Meet the Author

Robert Lanza, M.D. is currently Chief Scientific Officer at Advanced Cell Technology, and Adjunct Professor of Surgical Sciences at Wake Forest University School of Medicine. He has several hundred scientific publications and patents, and over 30 books, including Principles of Tissue Engineering (1st through 4th Editions), Methods of Tissue Engineering, Principles of Cloning (1st and 2nd Editions), Essentials of Stem Cell Biology (1st and 2nd Editions), XENO, Yearbook of Cell & Tissue Transplantation, One World: The Health & Survival of the Human Species in the 21st Century (as editor, with forewords by C. Everett Koop and former President Jimmy Carter), and Medical Science & the Advancement of World Health. Dr. Lanza received his B.A. and M.D. degrees from the University of Pennsylvania, where he was both a University Scholar and Benjamin Franklin Scholar. He is a former Fulbright Scholar, and studied as a student in the laboratory of Richard Hynes (MIT), Jonas Salk (The Salk Institute), and Nobel laureates Gerald Edelman (Rockefeller University) and Rodney Porter (Oxford University). He also worked closely (and coauthored a series of papers) with the late Harvard psychologist B.F. Skinner and heart transplant pioneer Christiaan Barnard. Dr. Lanza's current area of research focuses on the use of stem cells in regenerative medicine.

Read More Show Less

Read an Excerpt

Essentials of Stem Cell Biology


Academic Press

Copyright © 2009 Elsevier Inc.
All right reserved.

ISBN: 978-0-08-088497-4


Chapter One

Pluripotential Stem Cells from Vertebrate Embryos: Present Perspective and Future Challenges

Richard L. Gardner

INTRODUCTION

Many have contributed to the various developments that brought recognition of the enormous potential of cells of early embryonic origin for genetic modification of organisms, regenerative medicine, and in enabling investigation of facets of development that are difficult to explore in vivo. However, historically, this field is firmly rooted in the pioneering work of Roy Stevens and Barry Pierce on mouse teratomas and teratocarcinomas, tumors which continued for some time after these workers had embarked on their studies to be regarded with disdain by many mainstream pathologists and oncologists. While Stevens developed and exploited mouse strains with high incidences of such tumors to determine their cellular origins, Pierce focused his attention on the nature of the cell that endowed teratocarcinomas with the potential for indefinite growth which the more common teratomas lacked. Conversion of solid teratocarcinomas to an ascites form proved a significant advance in enabling dramatic enrichment of the morphologically undifferentiated cells in such tumors which their stem cells were expected to be included among. Then, in an experiment of heroic proportions, Kleinsmith and Pierce showed unequivocally that, on transplantation to histocompatible adult hosts, individual morphologically undifferentiated cells could form self-sustaining teratocarcinomas that contained as rich a variety of differentiated tissues as the parent tumor. Hence, the embryonal carcinoma (EC) cell, as the stem cell of teratocarcinomas has come to be known, was the first self-perpetuating pluripotential cell to be characterized. Though teratocarcinomas were obtained initially as a result of genetically-determined aberrations in the differentiation of male or female germ cells, it was found later that they could also be established in certain genotypes of mice by grafting early embryos ectopically in adults. Adaptation of culture conditions to enable EC cells to be perpetuated in an undifferentiated state or induced to differentiate in vitro soon followed. Although the range of differentiation detected in these circumstances was more limited than in vivo, it could nevertheless be quite impressive. Research on murine EC cells, in turn, provided the impetus for obtaining and harnessing the human counterpart of these cells from testicular tumors for in vitro study.

One outstanding question regarding the use of murine EC cells as a model system for studying aspects of development remained, namely the basis of their malignancy. Was this a consequence of genetic change or simply because such "embryonic" cells failed to relate to the ectopic sites into which they were transplanted? The obvious way of addressing this was to ask how EC cells behave when placed in an embryonic rather than an adult environment. This was done in three different laboratories by injecting the cells into blastocyst stage embryos. The results from each laboratory led to the same rather striking conclusion. EC cells which if injected into an adult, would grow progressively and kill it, were able to participate in entirely normal development following their introduction into the blastocyst. Using genetic differences between donor and host as cell markers, EC cells were found to be able to contribute to most if not all organs and tissue of the resulting offspring. Most intriguingly, according to reports from one laboratory, this could very exceptionally include the germline. The potential significance of this finding was considerable in terms of its implications for possible controlled genetic manipulation of the mammalian genome. This is because it raised the prospect of being able to select for very rare events, and thus bring the scope for genetic manipulation in mammals closer to that in microorganisms.

There were problems, however. One was that the EC contribution in chimeric offspring was typically both more modest and more patchy than that of cells transplanted directly between blastocysts. The chimeras also not infrequently formed tumors, with those that proved to be teratocarcinomas often being evident already at birth. Therefore, it seems likely that regulation of growth of atleast some of the transplanted EC cells failed altogether. Other chimeras developed more specific tumors such as rhabdomyosarcomas as they aged which were also clearly of donor origin, thereby revealing that the transplanted EC cells had progressed further along various lineages before their differentiation went awry. In extreme cases the transplanted EC cells disrupted development altogether so that fetuses did not survive to birth. Although the best EC lines could give very widespread contributions throughout the body of chimeras, they did so only very exceptionally. Finally, the frequency with which colonization of the germ line could be obtained with EC cells was too low to enable them to be harnessed for genetic modification. It seemed likely, therefore, that the protracted process of generating teratocarcinomas in vivo and then adapting them to culture militated against retention of a normal genetic constitution by their stem cells. If this was indeed the case, the obvious way forward was to see if such stem cells could be obtained in a less circuitous manner. This prompted investigation of what happens when murine blastocysts are explanted directly on growth-inactivated feeder cells in an enriched culture medium. The result was the derivation of lines of cells that were indistinguishable from EC cells in both morphology and expression of various antigenic and other markers, as well as in the appearance of the colonies they formed during growth. Moreover, like EC cells, these self-perpetuating blastocyst-derived stem cells could form aggressive teratocarcinomas in both syngeneic and immunologically compromised non-syngeneic adult hosts. They differed from EC cells principally in giving much more frequent and widespread somatic chimerism following reintroduction into the preimplantation conceptus and, if tended carefully, also in routinely colonizing the germline. Moreover, when combined with host conceptuses whose development was compromised by tetraploidy, they could sometimes form offspring in which no host-derived cells were discernible. Thus, these cells, which exhibited all the desirable characteristics of EC cells and few of their shortcomings, came to be called embryonic stem (ES) cells. Once it had been shown that ES cells could retain their ability to colonize the germline after in vitro transfection and selection, their future was assured. Surprisingly, however, despite the wealth of studies demonstrating their capacity for differentiation in vitro, particularly in the mouse, the idea of harnessing ES cells for therapeutic purposes took a long time to take root. Thus, although Robert Edwards explicitly argued the case that human ES cells might be used thus more than 25 years ago, it is only within the past decade that this notion has gained momentum, encouraged particularly by derivation of the first cell lines from human blastocysts.

TERMINOLOGY

There is some confusion in the literature about terminology in discussing the range of different types of cells that ES cells are able to form, an attribute that, in embryological parlance, is termed their potency. Some refer to these cells as being totipotent in recognition of the fact that, at least in the mouse, they have been shown to be able to give rise to all types of fetal cells and, under certain conditions, entire offspring. However, this is inappropriate on two counts. First, totipotency is reserved by embryologists for cells that retain the capacity to form an entire conceptus, and thus give rise to a new individual, unaided. Apart from the fertilized egg, the only cells that have so far been shown to be able to do this are blastomeres from early cleavage stages. Second, murine ES cells seem unable to form all the different types of cell of which the conceptus is composed. Following injection into blastocysts, they normally give rise only to cell types that are products of the epiblast or fetal precursor cell lineage. While they can also form derivatives of the primitive endoderm lineage which, for some obscure reason they do much more readily in vitro than in vivo, they have never been convincingly shown to contribute to the trophectodermal lineage. Hence, a widely adopted convention is to describe ES cells as pluripotent stem cells, to distinguish them from stem cells like those of the hematopoietic system which have a narrower, but nevertheless impressive, range of differentiative potential. A further source of confusion is the surprisingly common practice of referring to cells, particularly putative ES cells from mammals other than the mouse, as totipotent because their nuclei have been shown to be able to support development to term when used for reproductive cloning.

Another facet of terminology relates to the definition of an ES cell, which again is not employed in a consistent manner. One view, to which the author subscribes, is that use of this term should be restricted to pluripotent cells derived from pre- or peri-implantation conceptuses that can form functional gametes, as well as the full range of somatic cells of offspring. While there are considerable differences between strains of mice in the facility with which morphologically undifferentiated cell lines can be obtained from their early conceptuses, competence to colonize the germline as well as somatic tissues seems nevertheless to be common to lines from all strains that have yielded them. This is true, for example, even for the non-obese diabetic (NOD) strain whose lines have so far been found to grow too poorly to enable their genetic

ES-LIKE CELLS IN OTHER SPECIES

As shown in Table 1-1, cell lines that can be maintained for variable periods in vitro in a morphologically undifferentiated state have been obtained from morulae or blastocysts of a variety of species of mammals in addition to the mouse. They have also been obtained from the stage X blastoderms in the chick, and from blastulae in several different species of teleost fish. The criteria that have been employed to support claims that such lines are counterparts of murine ES cells are quite varied and, not infrequently, far from unequivocal. They range from maintenance of an undifferentiated morphology during propagation or expression of at least some ES cell markers, through differentiation into a variety of cell types in vitro, to production of histologically diverse teratomas or chimerism in vivo.

What such ES-like (ESL) cells lines have in common with murine ES cells, in addition to a morphologically undifferentiated appearance and expression of various genes associated with pluripotency, is a high nuclear/cytoplasmic ratio. Among the complications in assessing cell lines in different species is variability in morphology of the growing colonies. While colonies of ESL cells in the hamster and rabbit are very similar to those of murine ES cells, those of most other mammals are not. This is particularly true in the human whose undifferentiated ESL cell colonies closely resemble those formed by human EC cells of testicular origin, as also are those of ESL cells from other primates. In the marmoset, rhesus monkey, and human, ESL cells not only form relatively flattened colonies, but also exhibit a number of differences from mouse ES cells in the markers they express. Since they closely resemble human EC cells in all these respects, the differences were assumed until recently to relate to species rather than cell type.

In two studies in the sheep, colonies are reported to look like those formed by murine ES cells initially, but then to adopt a more epithelial-like appearance rapidly thereafter. This change in morphology bears an intriguing similarity to the transition in conditioned medium of murine ES to so-called epiblast-like (EPL) cells which is accompanied by loss of their ability to colonize the blastocyst. Given that this transition is said to be completely reversible, whether a comparable one is occurring spontaneously in sheep clearly warrants further investigation.

In no species has production of chimeras with ESL cells rivalled that obtained with murine ES cells. Where it has been attempted, both the rates and levels of chimerism are typically much lower than those found with murine ES cells. An apparent exception is one report for the pig, in which 72% of offspring were judged to be chimeric. However, this figure is presented in an overview of work that remains unpublished, and no details are provided regarding the number of times the donor cells had been passaged before being injected into blastocysts. In a subsequent study in this species using ES-like cells that had been through 11 passages, one chimera was recorded among 34 offspring. However, as the authors of this latter study point out, rates of chimerism of only 10–12% have been obtained following direct transfer of ICM cells in the pig. Hence, technical limitations may have contributed to the low success with ES-like cells in this species.

The only species listed in Table 1-1 in which colonization of the germline has been demonstrated are the chicken and the zebra fish, but in both cases this was with cells that had been passaged only 1–3 times before being injected into host embryos. Stem cells from early chick embryos that have been passaged for longer can give strong somatic chimerism, but have not yet been shown to be able to yield gametes. Consequently, in conformity with the terminology discussed earlier, morphologically undifferentiated cell lines in all species listed in Table 1-1 except the mouse

Generally, the strategy for attempting to derive ES cell lines in other species has been initially to follow more or less closely the conditions that proved successful in the mouse, namely the use of enriched medium in conjunction with growth-inactivated feeder cells and either leukemia inhibitory factor (LIF) or a related cytokine. Various modifications that have been introduced subsequently include same-species rather than murine feeder cells and, in a number of species including the human, dispensing with LIF. Optimal conditions for deriving cell lines may differ from those for maintaining them. Thus, in one study in the pig use of same-species feeder cells was found to be necessary to obtain cell lines, although murine STO cells were adequate for securing their propagation thereafter. Feeder-free conditions were found to work best in the case of both the medaka and the gilthead sea bream. Moreover, the cloning efficiency of human ESL lines was improved in serum-free culture conditions.

Unexpectedly, despite being closely related to the mouse, the rat has proved particularly refractory to derivation of ES cell lines (see Table 1-1). So far, the only cell lines that have proved to be sustainable in longer term in this species seem to lack all properties of mouse ES cells apart from colony morphology. Indeed, except for the 129 strain of mouse, establishing cells lines that can be propagated in vitro in a morphologically undifferentiated state seems almost more difficult in rodents than in most of the other vertebrates in which it has been attempted.

Overall, one is struck by species variability in the growth factors, status of conceptus or embryo, and other requirements for obtaining pluripotential cell lines in species other than the mouse. So far, one can discern no clear recipe for success. Of course, obtaining cells that retain the capacity to colonize the germline following long-term culture is essential only for the purpose of genetically-modifying animals in a controlled manner. Having cells that fall short of this but are nevertheless able to differentiate into a range of distinct types of cells in vitro may suffice for many other purposes, including regenerative medicine.

Recent Findings on Mouse Epiblast Cells

Recent findings in the mouse which may help to explain the differing experiences in other species emerged from attempts to derive ES cells from the epiblast of early post-implantation conceptuses. Stem cells exhibiting pluripotency could be obtained thus, but these clearly differed from true ES cells from pre-implantation conceptuses in conditions for their derivation and maintenance, their colony morphology, and also in how their differentiation was induced. Most interestingly, they not only resembled human ESL cells in these respects, but also almost entirely lacked the ability to yield chimerism following introduction into pre-implantation conceptuses. This raises the intriguing possibility that the mouse is peculiar in being permissive for derivation stem cells at an earlier stage in the epiblast lineage than other species. These novel pluripotential mouse cell lines have been termed "epiblast stem cells" or EpiSc.

(Continues...)



Excerpted from Essentials of Stem Cell Biology Copyright © 2009 by Elsevier Inc. . Excerpted by permission of Academic Press. All rights reserved. No part of this excerpt may be reproduced or reprinted without permission in writing from the publisher.
Excerpts are provided by Dial-A-Book Inc. solely for the personal use of visitors to this web site.

Read More Show Less

Table of Contents

FOREWORD
Why Stem Cell Research?
A New Path-Induced Pluripotent Stem Cells
Embryonic Stem Cells Versus Adult Stem Cells
'Stemness': Definitions, Criteria and Standards
PART ONE: INTRODUCTION TO STEM CELLS
PART TWO: BASIC BIOLOGY/MECHANISMS
PART THREE: TISSUE AND ORGAN DEVELOPMENT
PART FOUR: METHODS
PART FIVE: APPLICATIONS
PART SIX: REGULATION AND ETHICS
Epilogue: Concluding Statement

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)